|
EZBiolab Inc
mog peptide (mogp) ![]() Mog Peptide (Mogp), supplied by EZBiolab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mog peptide (mogp)/product/EZBiolab Inc Average 90 stars, based on 1 article reviews
mog peptide (mogp) - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
FUJIFILM
chls chl ![]() Chls Chl, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chls chl/product/FUJIFILM Average 90 stars, based on 1 article reviews
chls chl - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
GL Biochem
mog 35–55 peptide ![]() Mog 35–55 Peptide, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mog 35–55 peptide/product/GL Biochem Average 90 stars, based on 1 article reviews
mog 35–55 peptide - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
CPC Scientific
mog 35–55 peptide (mogp ![]() Mog 35–55 Peptide (Mogp, supplied by CPC Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mog 35–55 peptide (mogp/product/CPC Scientific Average 90 stars, based on 1 article reviews
mog 35–55 peptide (mogp - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Biomatik
mog 35–55 peptide mogp ![]() Mog 35–55 Peptide Mogp, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mog 35–55 peptide mogp/product/Biomatik Average 90 stars, based on 1 article reviews
mog 35–55 peptide mogp - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Hemmo Pharmaceuticals
peptides mog 35–55 (mog2) ![]() Peptides Mog 35–55 (Mog2), supplied by Hemmo Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/peptides mog 35–55 (mog2)/product/Hemmo Pharmaceuticals Average 90 stars, based on 1 article reviews
peptides mog 35–55 (mog2) - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
ANSYS inc
generic algorithm ansys moga ![]() Generic Algorithm Ansys Moga, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/generic algorithm ansys moga/product/ANSYS inc Average 90 stars, based on 1 article reviews
generic algorithm ansys moga - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
ANSYS inc
embedded moga method ![]() Embedded Moga Method, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/embedded moga method/product/ANSYS inc Average 90 stars, based on 1 article reviews
embedded moga method - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
BioResource International Inc
δ moba ![]() δ Moba, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/δ moba/product/BioResource International Inc Average 90 stars, based on 1 article reviews
δ moba - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Biosynth Carbosynth
mog35 55 peptide mogp ![]() Mog35 55 Peptide Mogp, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mog35 55 peptide mogp/product/Biosynth Carbosynth Average 92 stars, based on 1 article reviews
mog35 55 peptide mogp - by Bioz Stars,
2026-05
92/100 stars
|
Buy from Supplier |
|
ANSYS inc
moga ![]() Moga, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/moga/product/ANSYS inc Average 90 stars, based on 1 article reviews
moga - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
WET Labs Inc
sbe ecopucks ![]() Sbe Ecopucks, supplied by WET Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sbe ecopucks/product/WET Labs Inc Average 90 stars, based on 1 article reviews
sbe ecopucks - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: 13R-/- mice develop early onset and more severe EAE. 13R+/+ and 13R-/- C57BL/6 mice (6-8 per group) were induced for EAE with 300μg MOGp and monitored daily for clinical signs of paralysis. (A, B) Mean clinical score of disease severity ± SD and percentage of mice that remained disease free for the initial 10 day-phase of disease onset. (C) Shows the mean clinical score of disease severity ± SD for the entire 30 day-monitoing phase. (D-F) Show mean clinical score of disease severity ± SD for 13R+/+ and 13R-/- mice (6 mice per group) induced for EAE with 100 (D), 60, (E) or 20 (F) μg of MOGp. *p<0.05, **p<0.01 as determined by Mann-Whitneys U test. (G-I) Draining lymph nodes were harvested at day 10 post-disease induction from mice induced for EAE with 100μg MOGp and the cells were stimulated with PMA and ionomycin (G, H,) or graded concentrations of MOGp (I) and IFNγ and IL-17 responses were measured. (G) Shows the percentages while (H) illustrates the absolute numbers of cytokine secreting CD4+MOGtet+ T cells. (I) Shows cytokine secretion as measured by ELISA. Data is representative of at least 3 independent experiments. *p<0.05, **p<0.01, ***p<0.001 as determined by two-tailed, unpaired Student's t-test.
Article Snippet:
Techniques: Enzyme-linked Immunosorbent Assay, Two Tailed Test
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: EAE was induced in 13R+/+ and 13R-/- C57BL/6 mice using 100 μg MOGp, the LN and CNS were harvested at the indicated days post-disease induction, and CD4+MOGtet+ T cells were analysed ex vivo for intracellular IFNγ and IL-17. (A) Shows the frequency of single as well as double cytokine producing CD4+MOGtet+ T cells in both the LN and the CNS. (B) Shows the absolute cell numbers accumulated in the CNS of CD4+MOGtet+ T cells producing IL-17 (left panel), IFNγ (median panel), or both (right panel). The data is compiled from 3 independent experiments. *p<0.05, **p<0.01 as determined by two-tailed, unpaired Student's t-test.
Article Snippet:
Techniques: Ex Vivo, Two Tailed Test
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: (A, B) 13R+/+ and 13R-/- IL-17acre-eYFP mice were induced for EAE with 100 μg MOGp, the LN were harvested on day 7 post-disease induction and the frequency of YFP expressing CD4+IL-17+ (A) and CD4+IFNγ+ (B) T cells was determined by flow cytometry. (C-H) LN and CNS cells were harvested on days 4, 5 and 6 (C, D) or every 6 hours beginning on day 4 as indicated (E-H) and expression of Tbet and RoRγt by CD4+MOGtet+YFP+ cells was measured ex vivo by intracellular staining. (C, D) Show the frequency of CD4+MOGtet+YFP+ cells expressing Tbet and/or RoRγt in the LN (C) and CNS (D). (E-H) show the mean ± SD of the absolute numbers of CD4+MOGtet+YFP+ double positive for RoRγt and Tbet in (E, F) or Tbet single positive (G, H). Data is compiled from 3 independent experiments. *, p<0.05; **, p<0.01 as determined by two-tailed, unpaired Student's t-test.
Article Snippet:
Techniques: Expressing, Flow Cytometry, Ex Vivo, Staining, Two Tailed Test
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: Thy (A), SP (B), and LN (C) were harvested from naïve 13R+/+ and 13R-/- mice and the frequency of CD4+Foxp3+ Treg was determined by flow cytometry. (D, E) 13R+/+ and 13R-/- Foxp3-GFP mice were immunized with 100 μg MOGp s.c. in PBS/CFA and on day 10 post-immunization the SP cells were used to isolate effector Th1 and Th17 cells whereas the LN cells were utilized to sort CD4+CD25+Foxp3+(GFP+) Tregs. Effector Th1 and Th17 cells from 13R+/+ (D) and 13R-/- (E) mice were then co-cultured with the LN Tregs from both strains and suppression of effector function was evaluated by measuring residual IFNγ and IL-17 production by ELISA. The percent of residual cytokine represent the ratio of cytokine obtained in the presence of Tregs over cytokine produced in the absence of Tregs multiplied by 100. Data is representative of at least 3 independent experiments.
Article Snippet:
Techniques: Flow Cytometry, Cell Culture, Enzyme-linked Immunosorbent Assay, Produced
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: 13R+/+ and 13R-/- Foxp3-GFP mice were immunized with 100 μg MOGp s.c. in PBS/CFA and on day 10 post-immunization splenic effector Th1 cells from both strains were re-stimulated with PMA and ionomycin, isolated based on cytokine secretion and co-cultured with Tregs from the LN of 13R+/+ or 13R-/- mice. (A) Shows IFNγ production in cultures where the Th1 cells from either strain were co-cultured with Tregs from 13R+/+ mice at Treg/Th1 ratios of 1:1 and 1:4. (B) Shows the percent residual IFNγ production obtained at the indicated Treg:Th1 ratios (see Materials and Methods). The dashed lines indicate the inhibition ratios 50 (IR50), which is the Treg to T effector ratio at which the residual cytokine production is reduced by 50% (see Material and Methods). *p<0.05, **p<0.01 as determined by two-tailed, unpaired Student's t-test. (C) Shows the IR50± SD for Th1 effectors obtained with Tregs from 13R+/+ and 13R-/- mice. The SI (sensitivity index) represents the absolute amount of IFNγ that an effector Th1 cell could not produce due to suppression by Tregs (see Material and Methods). Data is compiled from 3 independent experiments.
Article Snippet:
Techniques: Isolation, Cell Culture, Inhibition, Two Tailed Test
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: 13R+/+ and 13R-/- Foxp3-GFP mice were immunized with 100 μg MOGp s.c. in PBS/CFA and on day 10 post-immunization splenic effector Th17 cells from both strains were re-stimulated with PMA and ionomycin, isolated based on cytokine secretion and co-cultured with Tregs from the LN of 13R+/+ or 13R-/- mice. (A) Shows IL-17 production in cultures where the Th17 cells from either strain were co-cultured with Tregs from 13R+/+ mice at Treg/Th17 ratios of 1:1 and 1:4. (B) Shows the percent residual IL-17 production obtained at the indicated Treg:Th17 ratios. The dashed lines indicate the IR50 at which the residual cytokine production is reduced by 50%. *p<0.05, **p<0.01 as determined by two-tailed, unpaired Student's t-test. (C) Shows the IR50± SD for Th17 effectors obtained with Tregs from 13R+/+ and 13R-/- mice. The SI represents the absolute amount of IL-17 that an effector Th17 cell could not produce due to suppression by Tregs. Data is compiled from 3 independent experiments.
Article Snippet:
Techniques: Isolation, Cell Culture, Two Tailed Test
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: 13R+/+ Foxp3-GFP and 13R-/- mice were immunized with 100μg MOGp s.c. in PBS/CFA and 10 days later the SP were used to isolate effector Th1 cells. Also, the LN from 13R+/+ Foxp3-GFP mice were utilized to sort CD4+CD25+GFP+(Foxp3+) Tregs to serve for suppression. The Th1 cells were then transferred (1 ×106 Th1 cells per mouse) i.v. into Rag2-/- C57BL/6 mice (6 mice per group) with or without Tregs (2.5 ×106 cells per mouse). On day 2 after transfer the hosts were induced for EAE with 100μg MOGp. (A) Shows the mean clinical scores ± SD for hosts recipient of Th1 effector cells from 13R+/+ mice without (13R+/+ + Nil) or with (13R+/+ + Tregs) Tregs. (B) Shows the mean clinical scores ± SD for hosts recipient of Th1 effector cells from 13R-/- mice without (13R-/- + Nil) or with (13R-/- + Tregs) Tregs. (C) Shows comparison of the mean clinical scores ± SD of hosts recipient of Tregs and Th1 effector cells from 13R+/+ versus 13R-/- mice. **p<0.01 as determined by Mann-Whitney U test.
Article Snippet:
Techniques: Comparison, MANN-WHITNEY
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Treg Suppression to Restrain Experimental Allergic Encephalomyelitis
doi: 10.4049/jimmunol.1700372
Figure Lengend Snippet: 13R+/+ Foxp3-GFP and 13R-/- mice were immunized with 100μg MOGp s.c. in PBS/CFA and 10 days later the SP were used to isolate effector Th17 cells. Also, the LN from 13R+/+ Foxp3-GFP mice were utilized to sort CD4+CD25+GFP+(Foxp3+) Tregs to serve for suppression. The Th17 cells were then transferred (4 ×106 Th17 cells per mouse) i.v. into Rag2-/- C57BL/6 mice (6 mice per group) with or without Tregs (2 ×106 cells per mouse). On day 2 after transfer the hosts were induced for EAE with 100μg MOGp. (A) Shows the mean clinical scores ± SD for hosts recipient of Th17 effector cells from 13R+/+ mice without (13R+/+ + Nil) or with (13R+/+ + Tregs) Tregs. (B) Shows the mean clinical scores ± SD for hosts recipient of Th17 effector cells from 13R-/- mice without (13R-/- + Nil) or with (13R-/- + Tregs) Tregs. (C) Shows comparison of the mean clinical scores ± SD of hosts recipient of Tregs and Th17 effector cells from 13R+/+ versus 13R-/- mice. **p<0.01 and ***p<0.001 as determined by Mann-Whitney U test.
Article Snippet:
Techniques: Comparison, MANN-WHITNEY
Journal: Biomedicines
Article Title: Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis
doi: 10.3390/biomedicines12030526
Figure Lengend Snippet: IFN-λ signaling in macrophages restrains the expansion of encephalitogenic Th17 cells but not Th1 cells. Encephalitogenic Th17 cell expansion by Ifnlr1 −/− macrophages. The proportion of ( A ) IL-17+ or ( B ) IFN-γ+ CD4 T cells in cultures following 3-day restimulation with MOGp in the presence of peritoneal macrophages from WT or Ifnr1 −/− mice. Each dot represents macrophages from an individual mouse. CD4 T cells were obtained from MOGp-immunized WT mice. Data represent mean ± SEM; ** p < 0.01; ns = not significant.
Article Snippet: The emulsion, composed of 150 μg of MOG35–55 peptide (sourced from GL Biochem, Shanghai Ltd., Shanghai, China) and complete Freund’s adjuvant (CFA) containing 500 μg of Mycobacterium tuberculosis (BD), was prepared using a homogenizer (Thermofisher Scientific, Waltham, MA, USA) operating at a maximum speed of 30,000 RPM for 1 min and 30 s. Briefly, mice were immunized with 150 μg of
Techniques: